BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31770611)

  • 1. Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity.
    Jägle S; Heeg M; Grün S; Rensing-Ehl A; Maccari ME; Klemann C; Jones N; Lehmberg K; Bettoni C; Warnatz K; Grimbacher B; Biebl A; Schauer U; Hague R; Neth O; Mauracher A; Pachlopnik Schmid J; Fabre A; Kostyuchenko L; Führer M; Lorenz MR; Schwarz K; Rohr J; Ehl S
    Clin Immunol; 2020 Jan; 210():108316. PubMed ID: 31770611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
    Leiding JW; Vogel TP; Santarlas VGJ; Mhaskar R; Smith MR; Carisey A; Vargas-Hernández A; Silva-Carmona M; Heeg M; Rensing-Ehl A; Neven B; Hadjadj J; Hambleton S; Ronan Leahy T; Meesilpavikai K; Cunningham-Rundles C; Dutmer CM; Sharapova SO; Taskinen M; Chua I; Hague R; Klemann C; Kostyuchenko L; Morio T; Thatayatikom A; Ozen A; Scherbina A; Bauer CS; Flanagan SE; Gambineri E; Giovannini-Chami L; Heimall J; Sullivan KE; Allenspach E; Romberg N; Deane SG; Prince BT; Rose MJ; Bohnsack J; Mousallem T; Jesudas R; Santos Vilela MMD; O'Sullivan M; Pachlopnik Schmid J; Průhová Š; Klocperk A; Rees M; Su H; Bahna S; Baris S; Bartnikas LM; Chang Berger A; Briggs TA; Brothers S; Bundy V; Chan AY; Chandrakasan S; Christiansen M; Cole T; Cook MC; Desai MM; Fischer U; Fulcher DA; Gallo S; Gauthier A; Gennery AR; Gonçalo Marques J; Gottrand F; Grimbacher B; Grunebaum E; Haapaniemi E; Hämäläinen S; Heiskanen K; Heiskanen-Kosma T; Hoffman HM; Gonzalez-Granado LI; Guerrerio AL; Kainulainen L; Kumar A; Lawrence MG; Levin C; Martelius T; Neth O; Olbrich P; Palma A; Patel NC; Pozos T; Preece K; Lugo Reyes SO; Russell MA; Schejter Y; Seroogy C; Sinclair J; Skevofilax E; Suan D; Suez D; Szabolcs P; Velasco H; Warnatz K; Walkovich K; Worth A; ; Seppänen MRJ; Torgerson TR; Sogkas G; Ehl S; Tangye SG; Cooper MA; Milner JD; Forbes Satter LR
    J Allergy Clin Immunol; 2023 Apr; 151(4):1081-1095. PubMed ID: 36228738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating mutations of STAT3: Impact on human growth.
    Gutiérrez M
    Mol Cell Endocrinol; 2020 Dec; 518():110979. PubMed ID: 32818584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3.
    Tanita K; Sakura F; Nambu R; Tsumura M; Imanaka Y; Ohnishi H; Kato Z; Pan J; Hoshino A; Suzuki K; Yasutomi M; Umetsu S; Okada C; Takagi M; Imai K; Ohara O; Muise AM; Okada S; Morio T; Kanegane H
    J Clin Immunol; 2021 May; 41(4):780-790. PubMed ID: 33501615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transducer and activator of transcription gain-of-function primary immunodeficiency/immunodysregulation disorders.
    Consonni F; Dotta L; Todaro F; Vairo D; Badolato R
    Curr Opin Pediatr; 2017 Dec; 29(6):711-717. PubMed ID: 28914637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8/STAT3, KIT/STAT3, and IL-2/CD25/Treg axes.
    Marega LF; Sabino JS; Pedroni MV; Teocchi M; Lanaro C; de Albuquerque DM; Dos Santos IP; Costa FF; Dos Santos Vilela MM
    Immunol Res; 2021 Oct; 69(5):445-456. PubMed ID: 34390446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype.
    Faletti L; Ehl S; Heeg M
    Biomed J; 2021 Aug; 44(4):412-421. PubMed ID: 34366294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel gain-of-function STAT3 variant in infantile-onset diabetes associated with multiorgan autoimmunity.
    Zhou Q; Chen D; Yu J; Zheng B; Zhou W; Jia Z; Zhang A; Gu W
    Mol Genet Genomic Med; 2024 Feb; 12(2):e2407. PubMed ID: 38404237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review.
    Fabre A; Marchal S; Barlogis V; Mari B; Barbry P; Rohrlich PS; Forbes LR; Vogel TP; Giovannini-Chami L
    J Allergy Clin Immunol Pract; 2019; 7(6):1958-1969.e9. PubMed ID: 30825606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.
    Milner JD; Vogel TP; Forbes L; Ma CA; Stray-Pedersen A; Niemela JE; Lyons JJ; Engelhardt KR; Zhang Y; Topcagic N; Roberson ED; Matthews H; Verbsky JW; Dasu T; Vargas-Hernandez A; Varghese N; McClain KL; Karam LB; Nahmod K; Makedonas G; Mace EM; Sorte HS; Perminow G; Rao VK; O'Connell MP; Price S; Su HC; Butrick M; McElwee J; Hughes JD; Willet J; Swan D; Xu Y; Santibanez-Koref M; Slowik V; Dinwiddie DL; Ciaccio CE; Saunders CJ; Septer S; Kingsmore SF; White AJ; Cant AJ; Hambleton S; Cooper MA
    Blood; 2015 Jan; 125(4):591-9. PubMed ID: 25359994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of gp130 signaling in T cells drives T
    Baumgartner F; Bamopoulos SA; Faletti L; Hsiao HJ; Holz M; Gonzalez-Menendez I; Solé-Boldo L; Horne A; Gosavi S; Özerdem C; Singh N; Liebig S; Ramamoorthy S; Lehmann M; Demel U; Kühl AA; Wartewig T; Ruland J; Wunderlich FT; Schick M; Walther W; Rose-John S; Haas S; Quintanilla-Martinez L; Feske S; Ehl S; Glauben R; Keller U
    Sci Signal; 2024 Feb; 17(824):eadc9662. PubMed ID: 38377177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 gain-of-function mutation in an adult patient.
    López AL; Niemela J; Stoddard J; Paolini MV; Rosenzweig S; Fernández Romero DS
    Medicina (B Aires); 2021; 81(6):1065-1068. PubMed ID: 34875609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short Stature in a Boy with Multiple Early-Onset Autoimmune Conditions due to a STAT3 Activating Mutation: Could Intracellular Growth Hormone Signalling Be Compromised?
.
    Sediva H; Dusatkova P; Kanderova V; Obermannova B; Kayserova J; Sramkova L; Zemkova D; Elblova L; Svaton M; Zachova R; Kolouskova S; Fronkova E; Sumnik Z; Sediva A; Lebl J; Pruhova S
    Horm Res Paediatr; 2017; 88(2):160-166. PubMed ID: 28253502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant function of pathogenic STAT3 mutant proteins is linked to altered stability of monomers and homodimers.
    Kasembeli MM; Kaparos E; Bharadwaj U; Allaw A; Khouri A; Acot B; Tweardy DJ
    Blood; 2023 Mar; 141(12):1411-1424. PubMed ID: 36240433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial growth hormone insensitivity and dysregulatory immune disease associated with de novo germline activating STAT3 mutations.
    Gutiérrez M; Scaglia P; Keselman A; Martucci L; Karabatas L; Domené S; Martin A; Pennisi P; Blanco M; Sanguineti N; Bezrodnik L; Di Giovanni D; Caldirola MS; Azcoiti ME; Gaillard MI; Denson LA; Zhang K; Husami A; Yayah Jones NH; Hwa V; Revale S; Vázquez M; Jasper H; Kumar A; Domené H
    Mol Cell Endocrinol; 2018 Sep; 473():166-177. PubMed ID: 29378236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel STAT-3 gain-of-function variant with hypogammaglobulinemia and recurrent infection phenotype.
    Erdős M; Tsumura M; Kállai J; Lányi Á; Nyul Z; Balázs G; Okada S; Maródi L
    Clin Exp Immunol; 2021 Sep; 205(3):354-362. PubMed ID: 34050927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance.
    Warshauer JT; Belk JA; Chan AY; Wang J; Gupta AR; Shi Q; Skartsis N; Peng Y; Phipps JD; Acenas D; Smith JA; Tamaki SJ; Tang Q; Gardner JM; Satpathy AT; Anderson MS
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34115115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3-confusion-of-function: Beyond the loss and gain dualism.
    Lodi L; Faletti LE; Maccari ME; Consonni F; Groß M; Pagnini I; Ricci S; Heeg M; Simonini G; Azzari C; Ehl S
    J Allergy Clin Immunol; 2022 Nov; 150(5):1237-1241.e3. PubMed ID: 35750105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in mice.
    Schmitt EG; Toth KA; Risma SI; Kolicheski A; Saucier N; Berríos RJF; Greenberg ZJ; Leiding JW; Bleesing JJ; Thatayatikom A; Schuettpelz LG; Edwards JR; Vogel TP; Cooper MA
    JCI Insight; 2022 Nov; 7(21):. PubMed ID: 36136607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2D
    Masle-Farquhar E; Jackson KJL; Peters TJ; Al-Eryani G; Singh M; Payne KJ; Rao G; Avery DT; Apps G; Kingham J; Jara CJ; Skvortsova K; Swarbrick A; Ma CS; Suan D; Uzel G; Chua I; Leiding JW; Heiskanen K; Preece K; Kainulainen L; O'Sullivan M; Cooper MA; Seppänen MRJ; Mustjoki S; Brothers S; Vogel TP; Brink R; Tangye SG; Reed JH; Goodnow CC
    Immunity; 2022 Dec; 55(12):2386-2404.e8. PubMed ID: 36446385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.